María Díez-Campelo

40PUBLICATIONS
253CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical mycologyGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (40)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 29, 2026
Outcomes of patients with higher-risk myelodysplastic syndromes/neoplasms treated with hypomethylating agents + venetoclax-an analysis from the International Consortium for MDS (icMDS) VALIDATE database.

|Jun 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

|Jun 17, 2026
Mutational dynamics in patients with del(5q) MDS treated with lenalidomide prior to transfusion dependency-Molecular results from the Sintrarev clinical trial.

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

Pageof 7

Frequent Collaborators

16 joint publications

Valeria Santini

14 joint publications

Rami S Komrokji

12 joint publications

Uwe Platzbecker

10 joint publications

Matteo Giovanni Della Porta